Nutex Health Q1 Revenue Up 2.2% to $216.5M; EPS Hits $6.52
NUTX•Nutex Health’s Q1 revenue rose 2.2% to $216.5 million, driven by a 1.8% increase in its hospital division. Net income more than doubled to $46.8 million (EPS $6.52), operating cash flow climbed to $75.5 million, and net debt fell to $24.3 million.
1. Financial Highlights
Nutex Health reported first quarter revenue of $216.5 million, up 2.2% year-over-year, driven by a 1.8% rise in hospital division revenue. Net income attributable to the company climbed 120.6% to $46.8 million, with diluted EPS of $6.52, while adjusted EBITDA reached $57.6 million and operating cash flow totaled $75.5 million.
2. Hospital Division Performance
Total visits at the hospital division rose 3.1% to 49,742, with same-hospital visits up 0.6%. A meaningful portion of revenue was supported by higher acuity claims and the Independent Dispute Resolution process, where the company submits 50–60% of claims and prevails in over 85% of determinations.
3. Balance Sheet and Liquidity
As of March 31, 2026, Nutex Health held $207.3 million in cash and cash equivalents, up from $185.6 million at year-end 2025. Net long-term debt decreased to $24.3 million from $29.2 million, strengthening the balance sheet and liquidity position.
4. Growth Strategy and Outlook
The company remains on track to open three new hospitals later this year and has board approval to selectively self-develop new facilities through its real estate division. This strategic investment underscores management’s confidence in sustaining a development pace of three to five hospitals annually.
